Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
4.365
-2.175 (-33.26%)
At close: Mar 16, 2026, 4:00 PM EDT
4.380
+0.015 (0.34%)
Pre-market: Mar 17, 2026, 9:12 AM EDT
Lifecore Biomedical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lifecore Biomedical stock has a target of 5.50, which predicts a 26.00% increase from the current stock price of 4.37.
Price Target: $5.50 (+26.00%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Lifecore Biomedical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Hold → Buy Upgrades $5.5 | Hold → Buy | Upgrades | $5.5 | +26.00% | Mar 17, 2026 |
| Keybanc | Keybanc | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 4, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | May 21, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $6 | Hold | Reiterates | $6 | +37.46% | Jan 3, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $8 → $10 | Strong Buy | Maintains | $8 → $10 | +129.10% | Nov 22, 2024 |
Financial Forecast
Revenue This Year
132.47M
from 129.46M
Increased by 2.32%
Revenue Next Year
147.72M
from 132.47M
Increased by 11.51%
EPS This Year
-0.81
from -0.93
EPS Next Year
-0.64
from -0.81
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 136.7M | 153.7M | |||
| Avg | 132.5M | 147.7M | |||
| Low | 126.6M | 139.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.6% | 16.0% | |||
| Avg | 2.3% | 11.5% | |||
| Low | -2.2% | 4.9% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.64 | -0.45 |
| Avg | -0.81 | -0.64 |
| Low | -0.93 | -0.83 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.